» Articles » PMID: 29152486

Avatars to Personalized Medicine: of Mice and Men

Overview
Date 2017 Nov 21
PMID 29152486
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Humanized mice for immune checkpoint blockade in human solid tumors.

Yip H, Haupt C, Maresh G, Zhang X, Li L Am J Clin Exp Urol. 2019; 7(5):313-320.

PMID: 31763362 PMC: 6872471.


Liquid biopsy in tumors: opportunities and challenges.

Bai Y, Zhao H Ann Transl Med. 2019; 6(Suppl 1):S89.

PMID: 30613664 PMC: 6291575. DOI: 10.21037/atm.2018.11.31.

References
1.
Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T . Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res. 1999; 59(2):269-73. View

2.
Eichenmuller M, Trippel F, Kreuder M, Beck A, Schwarzmayr T, Haberle B . The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol. 2014; 61(6):1312-20. DOI: 10.1016/j.jhep.2014.08.009. View

3.
Ilmer M, Garnier A, Vykoukal J, Alt E, von Schweinitz D, Kappler R . Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma. Mol Cancer Ther. 2015; 14(12):2712-21. DOI: 10.1158/1535-7163.MCT-15-0206. View

4.
Cairo S, Armengol C, De Reynies A, Wei Y, Thomas E, Renard C . Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell. 2008; 14(6):471-84. DOI: 10.1016/j.ccr.2008.11.002. View

5.
Taniguchi K, Roberts L, Aderca I, Dong X, Qian C, Murphy L . Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002; 21(31):4863-71. DOI: 10.1038/sj.onc.1205591. View